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a b s t r a c t
Ventricular tachycardia (VT) may occur in patients after corrective surgery for tetralogy of Fallot (ToF),
and this can be a cause of sudden cardiac death. Macroreentrant VT is a unique mechanism in these
patients, although other mechanisms are involved in VT development. Owing to advances in electro-
physiological knowledge and medical technology, macroreentrant VT after corrective surgery for ToF can
be treated by catheter ablation. In the macroreentrant circuit of VT, several critical isthmuses (types 1–4)
could be included, and these are supported by anatomical obstacles and operative interventions in the
right ventricle. Linear radiofrequency (RF) application through the critical isthmus can terminate and
prevent the recurrence of macroreentrant VT. Among the critical isthmuses, the type 1 isthmus (between
the right ventricular outﬂow scar and tricuspid annulus) is the most common, but compared with the
other types of isthmuses, it is longer so and has a thicker myocardium. Therefore, higher-energy RF
application using irrigation and/or large-tip ablation catheters is usually required to complete the linear
conduction block. Since other isthmuses may simultaneously work as critical components of the
macroreentrant circuit, detailed mapping is encouraged before starting RF application in the type 1
isthmus. Since long-term evidence of the effectiveness of catheter ablation for VT in patients after ToF
repair is limited, hybrid treatment with implantable cardioverter deﬁbrillators (ICDs) would be a
reasonable strategy for secondary prevention of cardiac events, such as that in patients with other
underlying heart diseases. Indications of electrophysiological study, catheter ablation, and/or ICD
therapy for primary prevention of sudden cardiac death should be further examined in high-risk
patients after ToF repair.
& 2014 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
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1. Background
Tetralogy of Fallot (ToF), which is characterized by (1) a large
ventricular septal defect (VSD), (2) obstruction or narrowing of the
right ventricular outﬂow tract (RVOT), (3) overriding of the aorta,
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and (4) right ventricular (RV) hypertrophy, is the most common
form of cyanotic congenital heart disease, accounting for approxi-
mately 10% of congenital heart defects [1]. Because of advances in
surgical treatment for congenital heart diseases, long-term prog-
nosis of patients with ToF has improved. However, ventricular
tachycardia (VT), which may develop late after corrective surgery,
is a major cause of sudden cardiac death in these patients [2,3].
A previous study showed that the incidence of VT in these patients
is approximately 12%, with an 8.3% risk of sudden death (based on
35 years of follow-up) [4].
The ideal therapeutic strategy for VT in patients after corrective
surgery for ToF has not yet been established, and few data are available
on the results of long-term management of VT. VT, which develops
in these patients, is usually caused by a macroreentrant mechanism
supported by a circuit around an anatomical and/or surgical RV
obstacle [5,6], although other mechanisms (microreentrant and non-
reentrant mechanisms) are also involved. Descriptions of successful
catheter ablation for VT in ToF patients ﬁrst appeared in the early
1990s [7,8]. These began as isolated case reports and have grown to
small clinical series. Owing to advances in electrophysiological knowl-
edge and medical technology, the acute success rate of radiofrequency
(RF) catheter ablation in VT currently approaches 90%, although
recurrence of VT is observed in approximately 20% of the patients
[5,6,9–12]. This is probably because the characteristics of arrhythmo-
genic myocardium and the location, size, and length of the critical part
of the reentry circuit vary among patients.
RF catheter ablation for VT after ToF repair is still being developed.
In this article, we describe the recent therapeutic approaches for
macroreentrant VT in patients after corrective surgery for ToF and
discuss reasonable management in such patients.
2. Mapping procedures
Macroreentrant VT, which is supported by anatomical obstacles
and surgically related nonexcitable regions (surgical scars or
patches), is a unique form of VT and is believed to be the most
common mechanism of VT in patients after corrective surgery
for ToF [5,6,9–12]. VT due to other mechanisms (microreentrant
and/or nonreentrant mechanisms) also occurs in these patients,
but mapping and ablation procedures for non-macroreentrant VT
are similar to those for other VTs that develop in patients with
various other structural heart diseases. Accordingly, in this paper,
we focus on the mapping and ablation procedures for macroreen-
trant VT in patients after ToF repair.
Successful and safe catheter ablation is facilitated by an apprecia-
tion for anatomical particularities and surgical details. Morphologi-
cal analysis of clinically documented VT is also important. In these
patients, VT usually shows a left bundle branch block-like QRS
morphology and inferior frontal plane axis. A right bundle branch
block-like morphology may be present if the exit of the reentry
circuit is located on the septal aspect of the RV free wall (Fig. 1).
Therefore, preprocedural planning should include a careful review of
imaging studies (computed tomography and magnetic resonance
imaging), original surgical and interventional records, and 12-lead
electrocardiograms (ECGs) of all documented VTs.
Since the reentry circuit of VT is usually supported by complex
anatomy and extended arrhythmogenic myocardium, electrical
physiological study and catheter ablation should be performed
using a three-dimensional (3D) mapping system. Typically, the ﬁrst
step in the procedure is to induce tachycardia with programmed
electrical stimulation to conﬁrm the diagnosis and exclude supra-
ventricular tachycardia with aberrancy. If VT is already diagnosed by
previous electrophysiological studies, it seems reasonable that
voltage (substrate) mapping is ﬁrst accomplished before VT induc-
tion because programmed electrical stimulation may induce hemo-
dynamically unstable (clinically or nonclinically documented) VT,
which requires immediate external cardioversion to resume basic
rhythm.
Low-voltage myocardium is often identiﬁed at the RVOT and
septal area of the right ventricle. During voltage mapping, attention
should be paid to conﬁrm the presence or absence of a conduction
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Fig. 1. Ventricular tachycardia (VT). Two VTs were observed in this patient. VT-1 shows a left bundle branch block-like pattern (panel A), and VT-2 shows a right bundle
branch block-like pattern (panel B).
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isthmus, which can support the macroreentrant VT circuit in these
patients. Four common conduction isthmuses have been proposed
in the heart after ToF repair [5] (Fig. 2). Type 1 isthmus is located
between the RVOT (or adjacent RV scar) and tricuspid annulus (TA),
type 2 isthmus is located between the RVOT scar and pulmonary
valve (PV), type 3 isthmus is located between the PV and septal scar,
and type 4 isthmus is located between the septal scar and TA.
Among them, type 1 isthmuses are the most common, followed by
type 3 isthmuses. Type 4 isthmuses are less common, and impor-
tantly, a type 2 isthmus does not theoretically exist in patients in
whom the RVOT is reconstructed using a transannular patch.
Peak-to-peak bipolar amplitudes are displayed and color coded
with electrograms in the 3D mapping system. Local electrograms
o1.5 mV are usually deﬁned as low voltage, and electrograms
o0.5 mV are deﬁned as very low voltage [13]. At low-amplitude
sites, high-voltage pacing (unipolar pacing with 10 mA at a 2-ms
pulse width) should be performed to conﬁrm whether the site
is an electrically unexcitable scar (EUS) [14]. Anatomical isthmuses
are usually deﬁned as areas between the boundaries (such as
pulmonary artery¼PA, TA, VSD patch, or EUS).
After voltage mapping, programmed electrical stimulation is
performed to induce VT, which is highly inducible by such
stimulation. During the VT, abnormal local electrograms (frag-
mentation, late potential, mid-diastolic potential, or continuous
activity) are frequently recorded from the wider areas of low-
voltage myocardium. However, these abnormal electrograms do
not always function as the essential components of the reentry
circuit. In patients with hemodynamically tolerated VT, activation
and entrainment mapping is performed. If the mechanism of the
induced VT is macroreentry, the whole activation sequence can be
mapped in the right ventricle [15]. Entrainment pacing from the
critical isthmus of the reentry circuit shows concealed fusion
between the original VT activation and pacing impulse, and the
difference between the postpacing interval and cycle length of VT
is o30 ms [16,17]. Diastolic electrical activity is often recorded
from the critical isthmus of the VT. A single RF application at
the site may terminate the VT, and this suggests that the site is on
the essential part of the reentry circuit. However, such a simple
termination by RF application is insufﬁcient to prevent VT recur-
rence, as described later.
For unmappable VT (hemodynamic instability or termination
during mapping or entrainment pacing), the locations of isth-
muses in the reentry circuit are estimated by the results of pace
mapping. Critical isthmuses of the reentry circuit would be the
sites where the QRS morphology matches that of the VT (in more
than 10 of 12 ECG leads) with an interval from the pacing stimulus
to the onset of QRS morphology of 440 ms [18]. If VT can be
brieﬂy tolerated, the catheter is moved to the presumed isthmus
site during basic rhythm, and the VT is reinduced to conﬁrm
whether the position is on the circuit, either by entrainment
mapping or by termination during RF delivery [9,19].
In patients after ToF repair, abnormal low-voltage electro-
grams can be recorded from a very wide area of the right ventricle.
In such patients, activation mapping using both multipolar
electrode catheters (basket catheters) and ablation catheters
would be useful to determine the location of the macroreentrant
circuit.
3. Catheter ablation
A reentry circuit is supported by complex anatomy and a thick
and/or damaged myocardium; thus, high-energy RF application is
usually required to create the conduction block line through the
critical isthmus of the reentry circuit in patients after ToF repair.
A large-tip (8 mm) ablation catheter (50–60 W) or an open
irrigation catheter (30–50 W) can create larger or deeper RF
lesions than those created by a standard 4-mm-tip ablation
catheter [20,21]. Catheter stability may be improved by using a
steerable sheath [22].
As described above, four discrete anatomical isthmuses that
often support VT have been identiﬁed. Among them, the most
common is the type 1 isthmus, which is located between the
superior aspect of the TA and an unexcitable scar and/or patch in
the free wall of the RVOT. Therefore, in previous studies, ﬁrst
ablation was usually performed on the type 1 isthmus as follows. If
the induced VT was hemodynamically stable and entrainment
pacing showed the type 1 isthmus to be in the reentry circuit, a
line of RF lesions was placed to transect this isthmus. During
ablation, the cycle length of VT is generally prolonged, and VT is
then terminated. If VT is not stable for mapping, but pace mapping
or brief entrainment mapping indicates that the type 1 isthmus is
an essential part of the reentry circuit, a line of RF lesions is placed
across the type 1 isthmus during sinus rhythm. Successful creation
of the linear conduction block through the isthmus would be
conﬁrmed by (1) the absence of local capture during pacing along
the line, (2) double potentials during basic rhythm (or pacing)
along the line, and/or (3) demonstration of the conduction block
Fig. 2. Schematic representation of the four critical isthmuses for macroreentrant VT after corrective surgery for tetralogy of Fallot. The schema is quoted from Circulation
2007;116:2241–52
(Reference no. [5]: reproduced with permission).
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through the isthmus during pacing from above or below the line.
However, because of RV hypertrophy and a relatively longer length
of the isthmus, creation of a complete line conduction block
through the type 1 isthmus may be challenging in some patients
[23] (Fig. 3). On the other hand, type 2–4 isthmuses are shorter
and usually consist of damaged low-voltage myocardium [24,25],
which suggests that creation of a conduction block in these
isthmuses (types 2–4) is much easier than that in type 1 isthmuses.
In addition, if ablation to the type 1 isthmus is unsuccessful, an
incomplete conduction block through the isthmus may facilitate
VT recurrence. Therefore, before RF application to the type
1 isthmus, we carefully analyze the presence or absence of type
2–4 isthmuses and examine the possibility of whether ablation
to these isthmuses (types 2–4) could interrupt the reentrant
circuit of VT.
Moore et al. recently described the characterization of the
anatomy and histology of VT isthmuses in patients after surgical
repair of ToF [24]. In the 27 autopsied hearts, the length and wall
thickness of each anatomical isthmus were measured. In that
study, the region between the RVOT ventriculotomy site and TA
was classiﬁed as the type 1A isthmus and that between the RVOT
ventriculotomy site and VSD patch was deﬁned as the type 1B
isthmus. In patients aged Z5 years at death, type 1A and type 1B
isthmuses were present in 88%, type 2 isthmus in 25%, type 3
isthmus in 94%, and type 4 isthmus in 13%. Type 1A isthmus had
the greatest dimensions (mean length, 3.971.08; thickness,
1.570.3 cm), type 1B isthmus had intermediate dimensions
(mean length, 2.470.8; thickness, 1.170.4 cm), and type 2, type
3, and type 4 isthmuses had the smallest dimensions (mean
length, 1.570.5, 1.470.8, and 0.670.4 cm, respectively; thick-
ness, 0.570.2, 0.670.2, and 0.370.04 cm, respectively). This
study demonstrated that type 1A isthmus was frequently present,
but creation of linear transmural RF lesions through the isthmus
would be technically difﬁcult even when using irrigation and/or
large-tip ablation catheters.
4. Case presentation
To date, we have treated 12 patients with macroreentrant VT
after ToF repair. The following are some example cases of our
treatment experience [26].
4.1. Case 1
Two clinical VTs (VT1 and VT2) were induced by programmed
electrical stimulation, and the cycle lengths of both VTs were
350 ms. VT1 showed left bundle branch block-like morphology,
whereas VT2 showed right bundle branch block-like morphology
(Fig. 1). The activation wavefront of VT1 circulated counterclock-
wise around the operation scar, which existed in the RVOT passing
through the type 1 and type 2 isthmuses (Fig. 4). On the other
hand, the activation wavefront of VT2 propagated clockwise
around the same reentrant circuit (Fig. 4). We mapped these two
macroreentrant VTs using a single conventional catheter before a
3D mapping system was available for clinical electrophysiological
study. A fragmented local potential was recorded from the type
2 isthmus, and rapid pacing from the site demonstrated a
concealed entrainment phenomenon. RF application using a 4-
mm-tip ablation catheter (50 W) terminated the VT (Fig. 5), but
the same VTs were still inducible. Both VTs ﬁnally became
noninducible after linear RF applications between the PV and
operation scar at the RVOT (type 2 isthmus). In this patient, type
1 isthmus also worked as a critical part of the reentry circuit.
However, the type 1 isthmus was longer in length and consisted of
normal-voltage myocardium. After the RF ablation, no VT recurred
Transannular 
patch
Low-voltage area
Tricuspid annulus
Type-1 isthmus
≥1.00 mV
≤0.10 mV
Fig. 3. Voltage mapping of the right ventricle. This case is different from the one in Fig. 1. The outﬂow tract of this patient was reconstructed using a transannular patch. A
dense scar presented in the region of the transannular patch. An area where the endocardial electrograms were o1.0 mV in amplitude, limited to the area beside the
transannular patch. A long type 1 isthmus was present between the transannular patch and tricuspid annulus, and the local electrogram at the isthmus showed normal
voltage. The schema is quoted from Internal Medicine 2009;48:1021–3
(Reference no. [23]: reproduced with permission).
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during the follow-up period of 20 years. To the best of our
knowledge, this is the ﬁrst case report indicating that RF catheter
ablation of a type 2 isthmus successfully treated macroreentrant
VT after ToF repair [7].
As described in this patient's case, pleomorphic VT (pleural VTs
with monomorphic but different QRS morphologies) can be observed
in some patients after ToF repair. Forward and reverse propagation of
the activation wavefront through a single macroreentrant circuit is
one of the mechanisms of pleomorphic VTs [27]. Diagnosing this
mechanism by detailed mapping is important because creation of
a single conduction line through the critical isthmus can treat both
VTs simultaneously. Pleomorphic VTs can be induced because of
the coexistence of pleural macroreentrant circuits in the heart. In
such patients, creation of a conduction block line in each critical
Type-1 
isthmus
Type 2 
isthmus
Fig. 4. Activation mapping. This case is the same as the one in Fig. 1. The activation wavefront of VT-1 propagated in a counterclockwise direction around the operation scar
in the right ventricular free wall, whereas the activation wavefront of VT-2 circulated along the same obstacle in a clockwise direction. The activation wavefronts of both the
VTs passed through the type 1 and type 2 isthmuses, but the type 2 isthmus was shorter than the type 1 isthmus. LBBB-like pattern¼ left bundle branch block-like pattern,
RBBB-like pattern¼right bundle branch block-like pattern. RV(apex)¼right ventricular apex, HBE¼His-electrogram recording site, and Map¼mapping catheter. The schema
is quoted from Pacing and Clinical Electrophysiology 1997;20:2279–81
(Reference no. [27]: reproduced with permission).
I
II
V1
RV(apex)
RV(inflow)
Map (type 2 
isthmus)
RF (50 W) 
500 ms 5000 ms 
Fig. 5. Catheter ablation. This case is the same as the one in Fig. 1. During VT-1 mapping, a fragmented diastolic potential (marked by a bidirectional arrow) was recorded
from the type 2 isthmus (panel A). Using a standard 4-mm-tip ablation catheter, radiofrequency current (50 W) was applied to the site, and the VT terminated after
approximately 12 s (panel B). RV(apex)¼right ventricular apex, RV(inﬂow)¼right ventricular inﬂow, and Map¼mapping catheter.
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isthmus can eliminate the pleomorphic VTs. Pleomorphic VTs can
also be caused by the coexistence of macroreentrant, microreentrant,
and nonreentrant VTs. In such patients, treatment of all VTs solely
by using catheter ablation is difﬁcult, and hybrid treatment with
implantable cardiac deﬁbrillators (ICDs) is usually required, as
described below.
1.50 mV
0.10 mV
1.50 mV
0.10 mV
Fig. 6. Voltage mapping in the right ventricle. This case is different from the ones in Figs. 1 and 3. The right ventricular outﬂow tract was reconstructed using a transannular
patch. Wide low-voltage areas (o1.5 mV) were distributed in the anterior wall (panel A) and septal wall (panel B) of the right ventricle.
V1
Basket catheter (spline)
A
B
C
D
E
F
Map
(E-F)
275 ms 273 ms
PCL = 260 ms
200 ms
H
AB
C
D
E
F
G
Left anterior oblique (45°)
I
II
Fig. 7. Activation mapping using an ablation catheter and a basket catheter. This case is the same as the one in Fig. 6. A basket catheter was placed in the inﬂow area of the
right ventricle. The activation sequence of the VT propagated from spline A to spline E, but an activation gap was observed between splines E and F. When the mapping
catheter was moved to the site between the splines E and F, a fragmented diastolic potential was recorded. Rapid pacing (at a cycle length of 260 ms) from the site showed a
concealed entrainment phenomenon, and the ﬁrst postpacing cycle length at the site (275 ms) was almost identical to the cycle length of the VT (273 ms). PCL¼pacing cycle
length, and Map¼mapping catheter.
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4.2. Case 2
In this patient, the RVOT was reconstructed using a transan-
nular patch, and therefore, a type 2 isthmus was not created.
Three-dimensional voltage mapping demonstrated wide low-
voltage (or scar) areas in the RVOT and RV septum [28] (Fig. 6).
On the other hand, local electrograms distributed between the
RVOT scar and TA (type 1 isthmus) showed normal voltage. Clinical
VT was induced by programmed electrical stimulation with a cycle
length of 270–280 ms. We performed activation mapping using an
ablation catheter and a basket catheter (Fig. 7) and conﬁrmed that
the mechanism of the VT was macroreentry due to the activation
wavefront circulating around the TA through the type 4 isthmus
(Fig. 8). During the VT, a diastolic fragmented electrogram was
recorded from the lower RV septum (type 4 isthmus), and rapid
pacing from the site showed concealed entrainment (Fig. 8). RF
application to the site (50 W by a 4-mm-tip catheter) terminated
the VT, but the same VT was reinduced. After linear RF application
through the isthmus, double potentials were recorded on the
ablation line, and the VT became noninducible.
5. Role of ICD treatment
VT, which develops in patients after ToF repair, can be treated
by catheter ablation. However, the long-term results of catheter
ablation have not yet been clariﬁed. As described above, ablation
procedures targeting the critical isthmus of the macroreentrant
circuit are a standard treatment strategy; however, this strategy
recently became the standard approach only after 3D mapping
systems became available in clinical electrophysiological studies,
and therefore, follow-up results in patients in whom VTs were
treated by critical isthmus ablation are limited.
In patients with VT associated with various structural heart
diseases, ICD therapy is recommended even if the target VT is
successfully ablated and no VT is inducible after catheter ablation
[29]. This is because, in such patients, the same VT and/or new VT
recurs during the follow-up period because of the presence of an
arrhythmogenic myocardium in the heart and/or progression of
the underlying heart diseases (prior myocardial infarction, idio-
pathic dilated cardiomyopathy, arrhythmogenic RV dysplasia, or
cardiac sarcoidosis). In addition, ICD therapy is also recommended
for primary prevention of sudden cardiac death in patients with an
impaired left ventricular function (which is usually indicated by
a lower left ventricular ejection fraction of o30–35%) without
clinically documented VTs [29–31].
On the other hand, in patients after ToF repair, the left ventri-
cular ejection fraction is usually preserved, although myocardial
hypertrophy and/or dilation of the right ventricle persists and could
work as an arrhythmogenic substrate long after successful catheter
ablation. Therefore, it is reasonable that ICD therapy is recom-
mended in patients with aborted sudden cardiac death and/or
ventricular ﬁbrillation. ICD therapy is also recommended in patients
in whom programmed electrical stimulation induces nonclinically
documented microreentrant and/or nonreentrant VT in addition
to the clinically documented macroreentrant VT. In such patients,
the arrhythmogenic substrate might be extensively present in the
heart. However, indication of ICD therapy is controversial in
patients in whom hemodynamically stable clinically documented
macroreentrant VT is successfully treated and no other VT is
inducible after catheter ablation. We encountered few such patients
(Case 1) because these patients were treated before ICD devices
were available in our country. Although the clinical outcomes of
these patients have been uneventful, supplemental treatment with
ICDs may be necessary in such patients because recurrences of VT
after successful catheter ablation have been reported. Unlike that
for secondary prevention, the effectiveness of ICD therapy and/or
V1
A
B
C
D
E
F
Map
RF
Basket catheter (spline)
119 ms
-143 ms
I
II
Fig. 8. Catheter ablation and activation mapping. This case is the same as the one in Figs. 6 and 7. Three-dimensional mapping demonstrated that the activation wavefront of
the VT was circulating around the tricuspid annulus through the type 4 isthmus (left panel). VT was terminated following radiofrequency (RF) current application to the site
showing the concealed entrainment (right panel). Linear RF applications (marked by arrow) were delivered to the isthmus (left panel), and the VT became noninducible.
Map¼mapping catheter.
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catheter ablation for primary prevention of sudden cardiac death
has not yet been established. Although several factors (left and/or
RV dysfunction, late corrective surgery, a wider QRS width, and
presence of pulmonic valve regurgitation and/or RVOT stenosis)
have been proposed as future risks of cardiac events in patients
after ToF repair [4,32–35], the risk evaluation method and/or
therapeutic approach (using ICDs, catheter ablation, or antiarrhyth-
mic drugs) for primary prevention of sudden cardiac death should
be studied further.
6. Summary and conclusions
(1) VT, which develops in patients after ToF repair, includes a
macroreentrant mechanism, and its activation wavefront pro-
pagates through several critical isthmuses (types 1–4) created
by anatomical and surgical obstacles in the right ventricle.
(2) Creation of the linear conduction block through the critical
isthmus terminates and prevents the recurrence of macroreen-
trant VT. However, because of the distribution of the thick
myocardium and the long length of the isthmus, higher-energy
RF applications using irrigation and/or large-tip ablation cathe-
ters are usually required to complete the linear conduction block.
(3) Type 1 isthmuses are the most common, but compared with the
other isthmuses, they are longer and have a thicker myocardium.
(4) Long-term evidence of the effectiveness of RF ablation for VT
associated with ToF repair is limited. Therefore, supplemental
treatment with ICDs is recommended for secondary prevention
of cardiac events, especially in patients in whom non-
macroreentrant VT is observed clinically and/or induced by
programmed electrical stimulation. Indications of electrophy-
siological study, catheter ablation, and/or ICD therapy for
primary prevention of sudden cardiac death in high-risk
patients should be further examined.
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